List of Torrent Pharma Executive and Leadership Team

Leadership Overview

Torrent Pharma has 4 executives leading key functions including operations, finance, and quality assurance.

Driven by scientific excellence, Torrent Pharma is dedicated to developing high-quality, affordable medicines, maintaining a strong international presence and leadership across critical therapeutic areas.

Leadership Roles at Torrent Pharma

Executive Director & Chief Financial Officer - Sudhir Menon

Chief Operating Officer - Hasmukh Patel

Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) - Vidyasagar Gotpagar

Senior Executive Manager - Akash Vimal

Sudhir Menon - Executive Director & Chief Financial Officer

Sudhir Menon, the Executive Director & Chief Financial Officer at Torrent Pharma, directs the company's financial strategy and fiscal operations. Menon oversees all aspects of financial planning, accounting, treasury, and investor relations, ensuring robust financial health and sustainable growth. This leadership position involves managing capital allocation, driving profitability, and optimizing financial performance across Torrent Pharma's diverse business segments, including its significant presence in diabetology and oncology. Sudhir Menon's financial acumen is crucial for supporting the company's extensive research and development initiatives and its expanding international footprint. By maintaining rigorous financial discipline, Menon enables Torrent Pharma to continue developing high-quality, affordable medicines. The Chief Financial Officer's strategic guidance is instrumental in securing the company's long-term financial stability and supporting its mission of global healthcare improvement.

Hasmukh Patel - Chief Operating Officer

Hasmukh Patel, the Chief Operating Officer at Torrent Pharma, directs all operational facets of the company. Patel oversees the manufacturing and supply chain divisions, ensuring efficient production of high-quality pharmaceuticals. This leadership role involves optimizing internal processes to support the company's extensive therapeutic area portfolio, including cardiovascular health and central nervous system disorders. Patel's operational oversight extends to managing resources and driving productivity across all manufacturing sites. By focusing on operational excellence, Hasmukh Patel ensures the seamless delivery of affordable medicines to patients globally, aligning with Torrent Pharma's core mission of scientific innovation and accessibility. The Chief Operating Officer's strategic initiatives directly impact the company's ability to scale operations and maintain its competitive edge in both domestic and international markets.

Vidyasagar Gotpagar - Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations )

Vidyasagar Gotpagar, the Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ) at Torrent Pharma, executes stringent quality assurance protocols across contract manufacturing operations. Gotpagar is responsible for monitoring all locations to ensure adherence to regulatory standards and Torrent Pharma's commitment to high-quality, affordable medicines. This critical function involves detailed oversight of production processes, raw material sourcing, and finished product testing. The Executive LLM's role ensures that all contract-manufactured products meet the company's exacting specifications, particularly within key therapeutic areas like gastro-intestinal care and cosmo-dermatology. Vidyasagar Gotpagar's diligent monitoring safeguards product integrity and patient safety, reinforcing Torrent Pharma's reputation for excellence. This position is vital for maintaining compliance and driving continuous improvement in quality management systems across all external manufacturing partnerships.

Akash Vimal - Senior Executive Manager

Akash Vimal, the Senior Executive Manager at Torrent Pharma, manages critical operational and strategic initiatives that support the company's growth objectives. Vimal oversees key projects and cross-functional teams, ensuring alignment with Torrent Pharma's mission to deliver high-quality, affordable medicines worldwide. This role involves driving efficiency in business processes and contributing to the strategic planning for expansion into new markets and therapeutic areas, such as pain management and anti-infective treatments. Akash Vimal's responsibilities include enhancing operational effectiveness and supporting the integration of new scientific advancements into the company's product pipeline. The Senior Executive Manager's contributions are vital for maintaining Torrent Pharma's leadership position in the pharmaceutical industry and advancing its commitment to patient well-being through innovation and accessibility.

Explore Leadership Teams in Manufacturing

Eisai Global

Eisai is a global pharmaceutical manufacturing company founded in 1941. The company develops and produces medicines while focusing on a human health care approach that extends beyond traditional pharmaceutical services. Eisai operates across multiple regions including North America, Europe, Asia Pacific, and the Middle East, with a strong presence in countries such as the United States, Japan, China, and the United Kingdom. The company maintains a significant focus on research and development in the pharmaceutical sector, with particular emphasis on patient-centered healthcare solutions. Eisai's business model encompasses both business-to-business and business-to-consumer operations, reflecting its comprehensive approach to healthcare delivery and pharmaceutical development.

Company Leadership

Alnylam Pharmaceu...

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Company Leadership

Cresco Labs

Cresco Labs is a multi-state, vertically integrated cannabis company that controls its cultivation, manufacturing, extraction, and packaging practices. Its facilities are powered by agronomists, manufacturing experts, and state-of-the-art agricultural equipment, all of which drive their commitment to quality, purity, and consistency. Cresco Labs packages, ships and distributes its products nationwide, including locations owned and operated by their team. Cresco Labs is headquartered in Chicago, Illinois.

Company Leadership

Morepen

Morepen Laboratories is a leading pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs) and finished formulations. With a commitment to quality and innovation, the company offers a wide range of healthcare, grooming, and OTC products under trusted brands like Dr. Morepen and Gubb World, catering to over 100 million consumers. Morepen has a robust global presence, exporting to over 80 countries and holding certifications from regulatory authorities such as USFDA and WHO GMP. The company is dedicated to enhancing lives through its extensive research and development efforts and state-of-the-art manufacturing facilities.

Company Leadership

Frequently Asked Questions Regarding Torrent Pharma Top Executives and Leadership Team

Who leads Torrent Pharma?

Torrent Pharma is led by Sudhir Menon (Executive Director & Chief Financial Officer), along with executives such as Hasmukh Patel (Chief Operating Officer) and Vidyasagar Gotpagar (Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations )).

Who is part of Torrent Pharma’s executive team?

The executive team of Torrent Pharma includes leaders such as Sudhir Menon (Executive Director & Chief Financial Officer), Hasmukh Patel (Chief Operating Officer), Vidyasagar Gotpagar (Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations )) and other senior executives.

How many executives does Torrent Pharma have?

Torrent Pharma has 4 executives leading key business areas.

What roles are included in Torrent Pharma’s leadership team?

The leadership team of Torrent Pharma includes roles such as Executive Director & Chief Financial Officer, Chief Operating Officer, Executive LLM - Quality Assurance (Contract Manufacturing Operations (Chief Marketing Officer) (P2P) Monitoring At Locations ), Senior Executive Manager.